西点药业：取得发明专利证书

Core Points - The company has recently obtained an invention patent certificate from the National Intellectual Property Administration of the People's Republic of China [1] - The patent is titled "A Synthesis Method of Ruscogenin" and has a patent number of 8338136 [1] - The patent application date was July 28, 2025, and the authorization announcement date was October 10, 2025 [1] - The patent is owned by Jilin Xidian Pharmaceutical Technology Development Co., Ltd., and has a validity period of 20 years [1]